Investment Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.3M | Buy |
5,973
+1,899
| +47% | +$421K | 0.46% | 57 |
|
|
2025
Q4 | $931K | Buy |
4,074
+17
| +0.4% | +$3.87K | 0.33% | 70 |
|
|
2025
Q3 | $939K | Sell |
4,057
-13,247
| -77% | -$2.7M | 0.33% | 66 |
|
|
2025
Q2 | $3.21M | Buy |
17,304
+111
| +0.6% | +$20.6K | 1.22% | 22 |
|
|
2025
Q1 | $3.6M | Sell |
17,193
-6
| -0% | -$1.17K | 1.49% | 20 |
|
|
2024
Q4 | $3.06M | Buy |
17,199
+172
| +1% | +$31.6K | 1.26% | 22 |
|
|
2024
Q3 | $3.36M | Buy |
17,027
+17
| +0.1% | +$3.17K | 1.4% | 22 |
|
|
2024
Q2 | $2.92M | Buy |
17,010
+149
| +0.9% | +$24.7K | 1.31% | 22 |
|
|
2024
Q1 | $3.07M | Buy |
16,861
+13,319
| +376% | +$2.3M | 1.39% | 21 |
|
|
2023
Q4 | $549K | Buy |
3,542
+22
| +0.6% | +$3.21K | 0.27% | 86 |
|
|
2023
Q3 | $525K | Buy |
3,520
+1,417
| +67% | +$208K | 0.28% | 87 |
|
|
2023
Q2 | $283K | Sell |
2,103
-3,203
| -60% | -$470K | 0.15% | 113 |
|
|
2023
Q1 | $846K | Buy |
5,306
+36
| +0.7% | +$5.5K | 0.44% | 67 |
|
|
2022
Q4 | $852K | Sell |
5,270
-3,921
| -43% | -$601K | 0.45% | 67 |
|
|
2022
Q3 | $1.23M | Buy |
9,191
+3,991
| +77% | +$573K | 0.37% | 74 |
|
|
2022
Q2 | $796K | Buy |
5,200
+34
| +0.7% | +$5.2K | 0.39% | 67 |
|
|
2022
Q1 | $838K | Buy |
5,166
+19
| +0.4% | +$2.76K | 0.35% | 67 |
|
|
2021
Q4 | $697K | Buy |
5,147
+1,081
| +27% | +$128K | 0.28% | 75 |
|
|
2021
Q3 | $439K | Buy |
4,066
+21
| +0.5% | +$2.4K | 0.2% | 94 |
|
|
2021
Q2 | $456K | Sell |
4,045
-630
| -13% | -$71K | 0.21% | 92 |
|
|
2021
Q1 | $506K | Buy |
+4,675
| New | +$500K | 0.25% | 80 |
|
|
2020
Q3 | – | Sell |
-2,193
| Closed | -$215K | – | 130 |
|
|
2020
Q2 | $215K | Buy |
+2,193
| New | +$193K | 0.13% | 123 |
|
|
2020
Q1 | – | Sell |
-2,290
| Closed | -$203K | – | 127 |
|
|
2019
Q4 | $203K | Buy |
+2,290
| New | +$190K | 0.14% | 139 |
|
|
2019
Q3 | – | Sell |
-8,295
| Closed | -$603K | – | 147 |
|
|
2019
Q2 | $603K | Buy |
8,295
+853
| +11% | +$67K | 0.43% | 64 |
|
|
2019
Q1 | $600K | Sell |
7,442
-76
| -1% | -$6.22K | 0.43% | 65 |
|
|
2018
Q4 | $693K | Buy |
+7,518
| New | +$661K | 0.58% | 56 |
|
|
2018
Q3 | – | Sell |
-7,759
| Closed | -$719K | – | 120 |
|
|
2018
Q2 | $719K | Sell |
7,759
-214
| -3% | -$20.9K | 0.53% | 53 |
|
|
2018
Q1 | $755K | Buy |
7,973
+2,123
| +36% | +$233K | 0.56% | 55 |
|
|
2017
Q4 | $566K | Buy |
5,850
+67
| +1% | +$6.31K | 0.42% | 65 |
|
|
2017
Q3 | $514K | Buy |
5,783
+57
| +1% | +$4.34K | 0.44% | 64 |
|
|
2017
Q2 | $415K | Buy |
5,726
+116
| +2% | +$7.8K | 0.38% | 69 |
|
|
2017
Q1 | $366K | Sell |
5,610
-441
| -7% | -$27.7K | 0.35% | 76 |
|
|
2016
Q4 | $379K | Sell |
6,051
-8,914
| -60% | -$544K | 0.37% | 74 |
|
|
2016
Q3 | $944K | Buy |
+14,965
| New | +$969K | 0.53% | 64 |
|
|
2016
Q2 | – | Sell |
-11,152
| Closed | -$660K | – | 114 |
|
|
2016
Q1 | $660K | Buy |
+11,152
| New | +$622K | 0.43% | 72 |
|
Other funds holding ABBV
VCM
VPM
Investment Partners's ABBV Position: Q1 2026 in Review
Investment Partners increased its AbbVie (ABBV) stake by 47% in Q1 2026, buying an estimated $421K and bringing the position to 5,973 shares worth $1.3M. The position accounts for 0.46% of the portfolio, ranked #57.
Investment Partners first reported a position in ABBV in Q1 2016 and has held it in 35 quarters since. The position peaked at $3.6M in Q1 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Investment Partners held 5,973 shares of AbbVie worth $1.3M as of Q1 2026.
- Investment Partners bought 1,899 AbbVie shares in Q1 2026, an estimated $421K.
- AbbVie made up 0.46% of Investment Partners's portfolio in Q1 2026, its #57 holding.
- Investment Partners first reported a position in AbbVie in Q1 2016 and has held it in 35 quarters since.
- Investment Partners's AbbVie position peaked at $3.6M in Q1 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Investment Partners's 13F filing for Q1 2026, filed 5 May 2026.